M. Kathryn Fink - 13 Sep 2024 Form 4 Insider Report for STRYKER CORP (SYK)

Signature
/s/ Austin Y. Ke, attorney-in-fact for M Kathryn Fink
Issuer symbol
SYK
Transactions as of
13 Sep 2024
Net transactions value
-$2,580,875
Form type
4
Filing time
17 Sep 2024, 18:01:28 UTC
Previous filing
03 May 2024
Next filing
07 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYK Common Stock Sale $784,770 -2,121 -17% $370.00 10,042 13 Sep 2024 Direct F1
transaction SYK Common Stock Options Exercise $900,081 +7,347 +73% $122.51 17,389 16 Sep 2024 Direct
transaction SYK Common Stock Sale $93,191 -258 -1.5% $361.21 17,131 17 Sep 2024 Direct F1, F2
transaction SYK Common Stock Sale $483,945 -1,336 -7.8% $362.23 15,795 17 Sep 2024 Direct F1, F3
transaction SYK Common Stock Sale $172,194 -474 -3% $363.28 15,321 17 Sep 2024 Direct F1, F4
transaction SYK Common Stock Sale $231,500 -635 -4.1% $364.57 14,686 17 Sep 2024 Direct F1, F5
transaction SYK Common Stock Sale $177,904 -487 -3.3% $365.31 14,199 17 Sep 2024 Direct F1, F6
transaction SYK Common Stock Sale $341,822 -931 -6.6% $367.16 13,268 17 Sep 2024 Direct F1, F7
transaction SYK Common Stock Sale $169,269 -460 -3.5% $367.98 12,808 17 Sep 2024 Direct F1, F8
transaction SYK Common Stock Sale $250,955 -680 -5.3% $369.05 12,128 17 Sep 2024 Direct F1, F9
transaction SYK Common Stock Sale $49,665 -134 -1.1% $370.64 11,994 17 Sep 2024 Direct F1, F10
transaction SYK Common Stock Sale $568,518 -1,530 -13% $371.58 10,464 17 Sep 2024 Direct F1, F11
transaction SYK Common Stock Sale $157,222 -422 -4% $372.56 10,042 17 Sep 2024 Direct F1, F12
holding SYK Common Stock 398 13 Sep 2024 By 401K

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYK Employee Stock Option granted 02/08/2017 (right to buy) Options Exercise $0 -7,347 -100% $0.000000 0 16 Sep 2024 Common Stock 7,347 $122.51 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2024.
F2 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $360.785 to $361.35, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F3 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $361.865 to $362.72, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F4 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $362.84 to $363.835, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F5 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $364.215 to $364.92, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F6 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $364.935 to $365.925, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F7 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $366.56 to $367.56, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F8 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $367.625 to $368.585, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F9 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $368.735 to $369.645, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F10 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $369.855 to $370.79, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F11 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $370.87 to $371.87, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F12 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $372.205 to $373.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
F13 Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.